China Announces 13 Measures to Accelerate Hierarchical Healthcare System Reform
China Unveils 13 Measures to Accelerate Hierarchical Medical Diagnosis System
China has announced 13 specific measures to accelerate the construction of a hierarchical medical diagnosis and treatment system, a major policy initiative trending on Weibo and covered across Chinese media platforms.
Background
China healthcare system has long suffered from overconcentration at top-tier hospitals, where patients crowd emergency rooms and outpatient departments for minor ailments, while community health centers and county hospitals remain underutilized. The hierarchical diagnosis system aims to direct patients to appropriate care levels.
Key Measures
The 13 measures address multiple dimensions of the reform:
- Graded Diagnosis Referral System: Clear pathways directing patients from community clinics to secondary and tertiary hospitals based on condition severity
- Resource Allocation: Redistributing medical resources, equipment, and personnel to grassroots healthcare facilities
- Digital Health Infrastructure: Building information systems for cross-level referrals, shared medical records, and remote consultations
- Financial Incentives: Adjusting insurance reimbursement ratios to favor primary care utilization
- Workforce Development: Training and deploying more general practitioners to community health centers
- Integration of Traditional and Western Medicine: Leveraging traditional Chinese medicine at the primary care level
Why It Matters
This reform directly addresses the healthcare access issues exposed by incidents like the Shenzhen ambulance interception case, where a critically ill patient died after being diverted to an under-equipped private hospital. A properly functioning hierarchical system would ensure patients receive appropriate care at the right facility level.
Implementation Challenges
Previous attempts at hierarchical reform in China have faced resistance from both patients (who prefer top hospitals) and top-tier hospitals (which benefit from patient volume). The success of these measures will depend on addressing deeply entrenched patient behavior and institutional incentives.
Source: Weibo trending / Chinese State Media — April 9, 2026